Quality of life in childhood immune thrombocytopenia: International validation of the kids' ITP tools

Pediatric Blood and Cancer

Volumn 60, Issue 1, 2013, Pages 95-100

  Klaassen, Robert J ^a   Blanchette, Victor ^b   Burke, Tricia A ^c   Wakefield, Cindy ^b   Grainger, John D ^d   Gaedicke, Gerhard ^e   Riedlinger, Arne ^e   Dufort, Gustavo ^f   Citrin, Estela ^g   Reguerre, Yves ^h   Pellier, Isabelle ^h,i   Curtis, Christine ^b   Young, Nancy L ^c  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c LAURENTIAN UNIVERSITY   (Canada)

^d ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f Centro Hospitalario Pereira Rossell   (Uruguay)

^g Laboratorios Clausen   (Uruguay)

^h ANGERS UNIVERSITY HOSPITAL   (France)

ⁱ Centre de Recherche en Cancérologie   (France)

Author keywords

Child; Comparative study; Idiopathic; Multicenter study; Parents; Purpura; Quality of life; Questionnaires; Reproducibility of results; Thrombocytopenic

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD DISEASE; FEMALE; FRANCE; GERMANY; HUMAN; IMMUNE THROMBOCYTOPENIA; KIDS IMMUNE THROMBOCYTOPENIA TOOL; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY OF LIFE; SCHOOL CHILD; TEST RETEST RELIABILITY; THROMBOCYTOPENIA; UNITED KINGDOM; URUGUAY; VALIDITY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; HUMANS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS;

EID: 84870192156     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24257     Document Type: Article

References (24)

1. Sutor AH, Harms A, Kaufmehl K. Acute immune thrombocytopenia (ITP) in childhood: Retrospective and prospective survey in Germany. Semin Thromb Hemost 2001; 27: 253-267.
2. Zeller B, Helgestad J, Hellebostad M, et al. Immune thrombocytopenic purpura in childhood in Norway: A prospective, population-based registration. Pediatr Hematol Oncol 2000; 17: 551-558.
3. Iyori H, Bessho F, Ookawa H, et al. Intracranial hemorrhage in children with immune thrombocytopenic purpura. Japanese Study Group on childhood ITP. Ann Hematol 2000; 79: 691-695.
4. Kuhne T, Buchanan GR, Zimmerman S, et al. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group. J Pediatr 2003; 143: 605-608.
5. Neunert CE, Buchanan GR, Imbach P, et al. Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood 2008; 112: 4003-4008.
6. Kuhne T, Imbach P, Bolton-Maggs PH, et al. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: An observational study. Lancet 2001; 358: 2122-2125.
7. Klaassen RJ, Blanchette VS, Barnard D, et al. Validity, reliability, and responsiveness of a new measure of health-related quality of life in children with immune thrombocytopenic purpura: The Kids' ITP Tools. J Pediatr 2007; 150: 510-515.
8. Blanchette V, Imbach P, Andrew M, et al. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura [see comments]. Lancet 1994; 344: 703-707.
9. Blanchette VS, Luke B, Andrew M, et al. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura [see comments]. J Pediatr 1993; 123: 989-995.
10. Bolton-Maggs PH, Moon I. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines [see comments]. Lancet 1997; 350: 620-623.
11. Price VE, Klaassen RJ, Bolton-Maggs PH, et al. Measuring disease-specific quality of life in rare populations: A practical approach to cross-cultural translation. Health Qual Life Outcomes 2009; 7: 92.
12. Varni JW, Burwinkle TM, Seid M, et al. The PedsQL 4.0 as a pediatric population health measure: Feasibility, reliability, and validity. Ambul Pediatr 2003; 3: 329-341.
13. Ravens-Sieberer U, Bullinger M. Assessing health-related quality of life in chronically ill children with the German KINDL: First psychometric and content analytical results. Qual Life Res 1998; 7: 399-407.
14. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174.
15. Donner A, Eliasziw M. Sample size requirements for reliability studies. Stat Med 1987; 6: 441-448.
16. Varni JW, Limbers CA, Burwinkle TM. Parent proxy-report of their children's health-related quality of life: An analysis of 13, 878 parents' reliability and validity across age subgroups using the PedsQL 4.0 Generic Core Scales. Health Qual Life Outcomes 2007; 5: 2.
17. Bullinger M, Brutt AL, Erhart M, et al. Psychometric properties of the KINDL-R questionnaire: Results of the BELLA study. Eur Child Adolesc Psychiatry 2008; 17: 125-132.
18. Shrout PE, Spitzer RL, Fleiss JL. Quantification of agreement in psychiatric diagnosis revisited. Arch Gen Psychiatry 1987; 44(2) 172-177.
19. Snyder CF, Mathias SD, Cella D, Isitt JJ, Wu AW, Young J. Health-related quality of life of immune thrombocytopenic purpura patients: results from a web-based survey. Curr Med Res Opin 2008; 24(10) 2767-2776.
20. Zhou Z, Yang L, Chen Z, et al. Health-related quality of life measured by the Short Form 36 in immune thrombocytopenic purpura: a cross-sectional survey in China. Eur J Haematol 2007; 78(6) 518-523.
21. George JN, Mathias SD, Go RS, et al. Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials. Br J Haematol 2009; 144(3) 409-415.
22. Kuter DJ, Rummel M, Boccia R, et al. Romiplostim or standard of care in patients with immune thrombocytopenia. N Engl J Med 2010; 363(20) 1889-1899.
23. Engelen V, Detmar S, Koopman H, et al. Reporting health-related quality of life scores to physicians during routine follow-up visits of pediatric oncology patients: Is it effective? Pediatr Blood Cancer 2011.
24. Haverman L, Engelen V, van Rossum MA, Heymans HS, Grootenhuis MA. Monitoring health-related quality of life in paediatric practice: development of an innovative web-based application. BMC Pediatr 2011; 11: 3.